证券日报网讯12月15日，同益中在互动平台回答投资者提问时表示，公司定型并批量生产高分子纤维腱 绳产品是公司向高端制造、前沿科技领域发展的实力与决心的体现。公司高度重视人形机器人产业带来 的变革机遇，已组建专项研发团队。公司将在确保主业稳健发展的前提下，密切关注人形机器人产业技 术路线的迭代演进，力求在具备技术协同性的环节建立竞争优势。 ...

（文章来源：每日经济新闻） 每经AI快讯，12月5日，同益中在互动平台表示，公司机器人和人形机器人领域的市场开发进展顺利， 公司重点突破高分子腱绳"大拉力-低形变-长寿命"三角平衡技术问题，满足了机器人企业及关键部件对 柔性材料重承载、精度控制以及高寿命的技术要求，同时开发了多种与线轮、插销等部件相匹配的柔性 材料末端结束方式，研发并定型了系列高分子纤维腱绳产品，实现了批量生产，并进入工业应用领域多 家头部机器人企业供应商名录，陆续供应了多批多款产品，订单数量呈现明显增长趋势，但订单整体规 模还较小。 ...

Group 1 - The 2025 Hangzhou International Humanoid Robot and Robotics Technology Exhibition showcased over 200 global companies, highlighting advancements in the entire industry chain from components to application services [1][3][5] - Six major projects were successfully signed during the exhibition, including the establishment of two specialized pilot test bases and production lines capable of producing 1.6 million key components and 50,000 complete machines annually, indicating an acceleration in the development of upstream and downstream industries [1][3] - The humanoid robot industry is experiencing rapid growth, acting as a catalyst for many companies to transform and enter this emerging market, particularly in the Yangtze River Delta region [3][5] Group 2 - Companies are increasingly focusing on the development of new materials for robotic applications, with significant advancements in the field of dexterous hands, driven by the growing market demand [5] - A report by Morgan Stanley predicts that by 2050, the market size for humanoid robots in China will reach 6 trillion yuan, with a total of 59 million humanoid robots expected to be in circulation [5]